Clincosm LogoSign in Get a demo

Lymphocytic Leukemia, Chronic

Showing 26 - 31 of 31
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Infusion-related Adverse Events at Administration of MabThera in

Completed
  • Lymphocytic Leukemia, Chronic
  • rituximab [Mabthera/Rituxan]
  • Gaevle, Sweden
  • +17 more
Oct 29, 2016

Lymphocytic Leukemia, Chronic Trial in Argentina, Venezuela (Cyclophosphamide, Fludarabine, Rituximab)

Completed
Has Results
  • Lymphocytic Leukemia, Chronic
  • Buenos Aires, Argentina
  • +8 more
Mar 30, 2016

Lymphocytic Leukemia, Chronic Trial in United Kingdom (Rituximab, Chlorambucil)

Completed
Has Results
  • Lymphocytic Leukemia, Chronic
  • Birmingham, United Kingdom
  • +11 more
Mar 6, 2016

Lymphocytic Leukemia, Chronic Trial in Canada, United States (MGCD0103)

Completed
  • Lymphocytic Leukemia, Chronic
  • Kansas City, Missouri
  • +12 more
Jun 4, 2015

Lymphocytic Leukemia, Chronic Trial in Worldwide (bendamustine, chlorambucil, rituximab [MabThera/Rituxan])

Completed
Has Results
  • Lymphocytic Leukemia, Chronic
  • Pori, Finland
  • +84 more
Jun 24, 2015

Lymphocytic Leukemia, Chronic Trial in Salzburg (Bevacizumab)

Completed
Has Results
  • Lymphocytic Leukemia, Chronic
  • Salzburg, Austria
    (unnamed)
May 27, 2014